The impact of chronic in vivo glucocorticoid excess on the functional characteristics of human skin fibroblasts obtained from patients with endogenous Cushing's syndrome

European Journal of Endocrinology

Volumn 152, Issue 6, 2005, Pages 895-902

  Zervolea, Irene ^b   Pratsinis, Harris ^b   Tsagarakis, Stylianos ^a   Karavitaki, Niki ^a   Stathakos, Dimitri ^b   Thalassinos, Nikos ^a   Kletsas, Dimitris ^b  

^a EVANGELISMOS HOSPITAL   (Greece)

^b INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GELATINASE A; GLUCOCORTICOID; INTERSTITIAL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGE DISTRIBUTION; ARTICLE; CATABOLISM; CELL DENSITY; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CUSHING SYNDROME; ENZYME RELEASE; FEMALE; FIBROBLAST CULTURE; GEL; HUMAN; HUMAN CELL; HYPERCORTISOLISM; IN VIVO STUDY; LIVING DONOR; LONG TERM EXPOSURE; MALE; PHENOTYPE; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SEX DIFFERENCE; SKIN DEFECT; SKIN FIBROBLAST;

ADULT; BLOTTING, WESTERN; CELL GROWTH PROCESSES; COLLAGEN; CUSHING SYNDROME; FEMALE; FIBROBLASTS; GLUCOCORTICOIDS; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; SKIN DISEASES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 21344439812     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01913     Document Type: Article

References (36)

1. Boumpas DT, Chrousos GP, Wilder RL, Cupps TR & Balow JE. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Annals of Internal Medicine 1993 119 1198-1208.
2. Boscaro M, Barzon L, Fallo F & Sonino N. Cushing's syndrome. Lancet 2001 357 783-791.
3. Bourdeau I, Bard C, Noel B, Leclerc I, Cordeau MP, Belair M, Lesage J, Lafontaine L & Lacroix A. Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism. Journal of Clinical Endocrinology and Metabolism 2002 87 1949-1954.
4. Kleerekopper M & Schiebinger RJ. Skeletal recovery after treatment of Cushing's: still room for improvement. Journal of Clinical Endocrinology and Metabolism 1995 80 2856-2858.
5. Sapolsky RM. Stress, glucocorticoids. and damage to the nervous system: the current state of confusion. Stress 1996 1 1-19.
6. Sowers JR & Lippman HR. Cushing's syndrome due to ectopic ACTH production: cutaneous manifestations. Cutis 1985 36 351-352, 354.
7. Oikarinen A & Autio P. New aspects of the mechanism of corticosteroid-induced dermal atrophy. Clinical and Experimental Dermatology 1991 16 416-419.
8. Slavin J, Unemori E, Hunt TK & Amento E. Transforming growth factor beta (TGF-beta) and dexamethasone have direct opposing effects on collagen metabolism in low passage human dermal fibroblasts in vitro. Growth Factors 1994 11 205-213.
9. Oikarinen A, Haapasaari KM, Sutinen M & Tasanen K. The molecular basis of glucocorticoid-induced skin atrophy: topical glucocorticoid apparently decreases both collagen synthesis and the corresponding collagen mRNA level in human skin in vivo. British Journal of Dermatology 1998 139 1106-1110.
10. Autio P, Oikarinen A, Melkko J, Risteli J & Risteli L. Systemic glucocorticoids decrease the synthesis of type I and type III collagen in human skin in vivo. whereas isotretinoin treatment has little effect. British Journal of Dermatology 1994 131 660-663.
11. Durant S, Duval D & Homo-Delarche F. Factors involved in the control of fibroblast proliferation by glucocorticoids: a review Endocrine Reviews 1986 7 254-269.
12. Orth DN. Cushing's syndrome. New England Journal of Medicine 1995 332 791-803.
13. Kletsas D, Caselgrandi E, Barbieri D, Stathakos D, Franceschi C & Ottaviani E. Neutral endopeptidase-24.11 (NEP) activity in human fibroblasts during development and ageing. Mechanisms of Ageing and Development 1998 102 15-23.
14. Peterkofsky B & Diegelmann R. Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry 1971 10 988-994.
15. Zervolea I, Kletsas D & Stathakos D. Autocrine regulation of proliferation and extracellular matrix homeostasis in human fibroblasts. Biochemical and Biophysical Research Communications 2000 276 785-790.
16. Herron GS, Banda MJ, Clark EJ, Gavrilovic J & Werb Z. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. Journal of Biological Chemistry 1986 261 2814-2818.
17. Kletsas D, Stathakos D, Sorrentino V & Philipson L. The growth-inhibitory block of TGF-beta is located close to the G1/S border in the cell cycle. Experimental Cell Research 1995 217 477-483.
18. Kletsas D & Stathakos D. Quiescence and proliferative response of normal human embryonic fibroblasts in homologous environment. Effect of aging. Cell Biology International Reports 1992 16 103-113.
19. Cockayne D, Sterling KM Jr, Shull S, Mintz KP, Illeyne S & Cutronco KR. Glucocorticoids decrease the synthesis of type 1 procollagen mRNAs. Biochemistry 1986 25 3202-3209.
20. Meisler N, Shull S, Xie R, Long GL, Absher M, Connolly JP & Cutroneo KR. Glucocorticoids coordinately regulate type I collagen pro alpha 1 promoter activity through both the glucocorticoid and transforming growth factor beta response elements: a novel mechanism of glucocorticoid regulation of eukaryotic genes. Journal of Cellular Biochemistry 1995 59 376-388.
21. Clark SD, Kobayashi DK & Welgus HG. Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts. Journal of Clinical Investigation 1987 80 1280-1288.
22. Kylmaniemi M, Oikarinen A, Oikarinen K & Salo T. Effects of dexamethasone and cell proliferation on the expression of matrix metalloproteinases in human mucosal normal and malignant cells. Journal of Dental Research 1996 75 919-926.
23. Gomi M, Iida S, Tsugawa M, Itoh Y, Moriwaki K, Fujii H, Yamashita S, Tamaki T & Tarui S. In vitro studies of skin fibroblasts from a patient with a new type of primary cortisol resistance: glucocorticoid receptor status and glucocorticoid effect on DNA synthesis. Hormone and Metabolic Research 1987 19 328-330.
24. Minguell JJ, Martinez J & Walter T. Effect of hydrocortisone on the growth of human bone marrow fibroblasts. British Journal of Haematology 1982 52 307-310.
25. Rowe DW, Starman BJ, Fujimoto WY & Williams RH. Differences in growth response to hydrocortisone and ascorbic acid by human diploid fibroblasts. In Vitro 1977 13 S24-S30.
26. Germinario RJ, Mcquillan A, Oliveira M & Manuel S. Enhanced insulin stimulation of sugar transport and DNA synthesis by glucocorticoids in cultured human skin fibroblasts. Archives of Biochemistry and Biophysics 1983 226 498-505.
27. Sluke G & Schachtschabel DO. Long-term treatment with cortisol: influence on proliferation, aging and glycosaminoglycan synthesis of cultured human diploid fibroblasts (WI-38). Zeitschrift für Gerontologie 1988 21 68-73.
28. Russell JD, Russell SB & Trupin KM. Differential effects of hydrocortisone on both growth and coltagen metabolism of human fibroblasts from normal and keloid tissue. Journal of Cellular Physiology 1978 97 221-229.
29. Kondo H, Kasuga H & Noumura T. Effects of various steroids on in vitro lifespan and cell growth of human fetal lung fibroblasts (WI-38). Mechanisms of Ageing and Development 1983 21 335-344.
30. Grinnell F. Fibroblast-collagen-matrix contraction: growth-factor signalling and mechanical loading. Trends in Cell Biology 2000 10 362-365.
31. Gabbiani G. The role of contractile proteins in wound healing and fibrocontractive diseases. Methods and Achievements in Experimental Pathology 1979 9 187-206.
32. Coulomb B, Dubertret L, Bell E & Touraine R. The contractility of fibroblasts in a collagen lattice is reduced by corticosteroids. Journal of Investigative Dermatology 1984 82 341-344.
33. Almawi WY, Hess DA, Assi JW, Chudzik DM & Rieder MJ. Pretreatment with glucocorticoids enhances T-cell effector function: possible implication for immune rebound accompanying glucocorticoid withdrawal. Cell Transplantation 1999 8 637-647.
34. Kono T, Tanii T, Furukawa M, Mizuno N, Kitajima J, Ishii M & Hamada T. Correlation between ageing and collagen gel contractility of human fibroblasts. Acta Dermatologica Venereologica 1990 70 241-244.
35. Millis AJ, Hoyle M, McCue HM & Martini H. Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. Experimental Cell Research 1992 201 373-379.
36. Pratsinis H, Tsagarakis S, Zervolea I, Giannakopoulos F, Stathakos D, Thalassinos N & Kletsas D. Chronic in vivo exposure to glucocorticoids prolongs cellular lifespan: the case of Cushing's syndrome-patients' fibroblasts. Experimental Gerontology 2002 37 1237-1245.